{"id":2819,"date":"2020-09-30T06:45:00","date_gmt":"2020-09-30T06:45:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/valberedning-i-xvivo-perfusion-ab-publ-4\/"},"modified":"2020-09-30T06:45:00","modified_gmt":"2020-09-30T06:45:00","slug":"valberedning-i-xvivo-perfusion-ab-publ-4","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedning-i-xvivo-perfusion-ab-publ-4\/","title":{"rendered":"Valberedning i XVIVO Perfusion AB (publ)"},"content":{"rendered":"<div class=\"mfn-body\">\n<p>F\u00f6ljande personer har utsetts att ing\u00e5 i XVIVO Perfusions valberedning inf\u00f6r \u00e5rsst\u00e4mman 2021:<\/p>\n<p>Henrik Blomquist, utsedd av Bure Equity AB<br \/>Caroline Sj\u00f6sten, utsedd av Swedbank Robur Fonder AB<br \/>Martin Lewin, utsedd av Eccenovo AB<br \/>G\u00f6sta Johannesson, styrelsens ordf\u00f6rande<br \/>\u00a0<br \/>Utn\u00e4mningen har skett enligt den instruktion avseende principer f\u00f6r utseende av valberedning i bolaget som fastst\u00e4lldes vid \u00e5rsst\u00e4mman i XVIVO Perfusion AB (publ) den 27 april 2018. De aktie\u00e4gare som har utsett ledam\u00f6terna i valberedningen representerade sammanlagt 30 procent av samtliga aktier i bolaget per den 31 augusti 2020.<br \/>\u00a0<br \/>I valberedningens uppdrag ing\u00e5r att inf\u00f6r \u00e5rsst\u00e4mman 2021 bereda och l\u00e4mna f\u00f6rslag till (i) val av ordf\u00f6rande vid st\u00e4mman, (ii) beslut om antalet styrelseledam\u00f6ter, (iii) val av och beslut om arvoden till styrelsens ordf\u00f6rande och styrelseledam\u00f6terna, (iv) val av och beslut om arvoden till revisor och (v) beslut om ny valberedningsprocedur f\u00f6r det fall valberedningen anser att det \u00e4r n\u00f6dv\u00e4ndigt.<br \/>\u00a0<br \/>\u00c5rsst\u00e4mma i XVIVO Perfusion AB (publ) kommer att h\u00e5llas den 22 april 2021 i G\u00f6teborg. Aktie\u00e4gare som vill l\u00e4mna f\u00f6rslag till valberedningen \u00e4r v\u00e4lkomna att g\u00f6ra det i god tid f\u00f6re \u00e5rsst\u00e4mman 2021 s\u00e5 att valberedningen hinner beakta f\u00f6rslaget. F\u00f6rslag ska s\u00e4ndas till XVIVO Perfusion AB (publ), Att: Valberedningen, Box 53015, 400 14 G\u00f6teborg.<\/p>\n<p>G\u00f6teborg 30 september 2020<br \/>XVIVO Perfusion AB (publ)<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r ytterligare information, v\u00e4nligen kontakta:<\/strong><\/p>\n<hr\/>\n<p>Dag Andersson, VD, +46 31-788 21 50,\u00a0<a href=\"mailto:dag.andersson@xvivoperfusion.com\" target=\"_blank\" rel=\"nofollow noopener\">dag.andersson@xvivoperfusion.com<\/a><br \/>Christoffer Rosenblad, CFO, +46 73-519 21 59,\u00a0<a href=\"mailto:christoffer.rosenblad@xvivoperfusion.com\" target=\"_blank\" rel=\"nofollow noopener\">christoffer.rosenblad@xvivoperfusion.com<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><strong class=\"mfn-heading-1\">Om oss<\/strong><\/p>\n<hr\/>\n<p>XVIVO Perfusion AB \u00e4r ett medicinteknikbolag som utvecklar l\u00f6sningar och system f\u00f6r att bed\u00f6ma och bevara organ utanf\u00f6r kroppen, och f\u00f6r att selektera anv\u00e4ndbara organ och h\u00e5lla dem i optimal kondition i v\u00e4ntan p\u00e5 transplantation. XVIVO Perfusion AB har sitt huvudkontor i G\u00f6teborg och ytterligare kontor finns i Lund och i Denver, USA. XVIVO-aktien \u00e4r noterad p\u00e5 Nasdaq Stockholm och handlas under symbolen XVIVO. <br \/>Mer information finns att l\u00e4sa p\u00e5 hemsidan <a href=\"http:\/\/www.xvivoperfusion.com.\" target=\"_blank\" rel=\"nofollow noopener\">www.xvivoperfusion.com.<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-pdf\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/4c662507-49c0-4468-9129-4483f5c911af\/valberedning-i-xvivo-perfusion-ab-publ.pdf\" target=\"_blank\" rel=\"nofollow noopener\">Valberedning i XVIVO Perfusion AB (publ)<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>F\u00f6ljande personer har utsetts att ing\u00e5 i XVIVO Perfusions valberedning inf\u00f6r \u00e5rsst\u00e4mman 2021: Henrik Blomquist, utsedd av Bure Equity ABCaroline&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-2819","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-nomination"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Valberedning i XVIVO Perfusion AB (publ) - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedning-i-xvivo-perfusion-ab-publ-4\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Valberedning i XVIVO Perfusion AB (publ) - XVIVO\" \/>\n<meta property=\"og:description\" content=\"F\u00f6ljande personer har utsetts att ing\u00e5 i XVIVO Perfusions valberedning inf\u00f6r \u00e5rsst\u00e4mman 2021: Henrik Blomquist, utsedd av Bure Equity ABCaroline...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedning-i-xvivo-perfusion-ab-publ-4\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/valberedning-i-xvivo-perfusion-ab-publ-4\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/valberedning-i-xvivo-perfusion-ab-publ-4\\\/\",\"name\":\"Valberedning i XVIVO Perfusion AB (publ) - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2020-09-30T06:45:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/valberedning-i-xvivo-perfusion-ab-publ-4\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/valberedning-i-xvivo-perfusion-ab-publ-4\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/valberedning-i-xvivo-perfusion-ab-publ-4\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Valberedning i XVIVO Perfusion AB (publ)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Valberedning i XVIVO Perfusion AB (publ) - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedning-i-xvivo-perfusion-ab-publ-4\/","og_locale":"en_US","og_type":"article","og_title":"Valberedning i XVIVO Perfusion AB (publ) - XVIVO","og_description":"F\u00f6ljande personer har utsetts att ing\u00e5 i XVIVO Perfusions valberedning inf\u00f6r \u00e5rsst\u00e4mman 2021: Henrik Blomquist, utsedd av Bure Equity ABCaroline...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedning-i-xvivo-perfusion-ab-publ-4\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedning-i-xvivo-perfusion-ab-publ-4\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedning-i-xvivo-perfusion-ab-publ-4\/","name":"Valberedning i XVIVO Perfusion AB (publ) - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2020-09-30T06:45:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedning-i-xvivo-perfusion-ab-publ-4\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedning-i-xvivo-perfusion-ab-publ-4\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/valberedning-i-xvivo-perfusion-ab-publ-4\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Valberedning i XVIVO Perfusion AB (publ)"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2819","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2819"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}